SAGE - Sage Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue90,273---
Cost of Revenue282,107210,277120,756-
Gross Profit-191,834-210,277-120,756-
Operating Expenses
Research Development-210,277120,75669,357
Selling General and Administrative201,40462,87839,40725,293
Non Recurring----
Others----
Total Operating Expenses483,511273,155160,16394,650
Operating Income or Loss-393,238-273,155-160,163-94,650
Income from Continuing Operations
Total Other Income/Expenses Net20,3563,0351,176155
Earnings Before Interest and Taxes-393,238-273,155-160,163-94,650
Interest Expense----
Income Before Tax-372,882-270,120-158,987-94,495
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-372,882-270,120-158,987-94,495
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-372,882-270,120-158,987-94,495
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-372,882-270,120-158,987-94,495